Last reviewed · How we verify
Skin and Skin Structure Peptococcus Infection
Approved treatments
- Metro I.V. In Plastic Container · Baxter
- Mefoxin In Sodium Chloride 0.9% In Plastic Container
- Cefotan
- Epocelin
- Metronidazol · University of Oslo
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Skin and Skin Structure Peptococcus Infection patent landscape — cliff calendar, originator estates, attackable patents
- Skin and Skin Structure Peptococcus Infection treatment landscape brief
- Skin and Skin Structure Peptococcus Infection treatment updates RSS
Frequently asked questions about Skin and Skin Structure Peptococcus Infection
What drugs treat Skin and Skin Structure Peptococcus Infection?
Tracked treatments include Metro I.V. In Plastic Container, Mefoxin In Sodium Chloride 0.9% In Plastic Container, Cefotan, Epocelin, Metronidazol.
What is the treatment for Skin and Skin Structure Peptococcus Infection?
Standard treatment for Skin and Skin Structure Peptococcus Infection includes Metro I.V. In Plastic Container, Mefoxin In Sodium Chloride 0.9% In Plastic Container, Cefotan, Epocelin, Metronidazol. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Skin and Skin Structure Peptococcus Infection patent cliff · Skin and Skin Structure Peptococcus Infection CI report
- Treatment: Metro I.V. In Plastic Container · Baxter
- Treatment: Mefoxin In Sodium Chloride 0.9% In Plastic Container
- Treatment: Cefotan
- Treatment: Epocelin
- Treatment: Metronidazol · University of Oslo
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing